Although MRP3/ABCC3 transports fewer anticancer substrates than MRP1 [16], overexpression of MRP3 has been predicted to be a prognostic factor in childhood and adult acute lymphoblastic leukemia and adult acute myeloid leukemia [13] and pancreatic carcinoma [17]. Here, ABCC3 is linked to exocrine pancreatic carcinoma.